Physician profile
Heidi Bedont
NPI 1861852527
$870.41
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $472 · 2022: $212 · 2023: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $186.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $198.79 | 2021-2023 | |
| Evofem Biosciences, INC. | $153.35 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $75.12 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $54.29 | 2021-2023 | |
| Exeltis, USA INC. | $47.78 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $39.92 | 2022 | |
| Organon LLC | $35.08 | 2021-2023 | Nexplanon |
| Agile Therapeutics, INC. | $34.19 | 2021 | |
| Medtronic, INC. | $25.15 | 2022 | |
| Becton, Dickinson and Company | $22.87 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $22.48 | 2023 | Bd Onclarity |
| Idorsia Pharmaceuticals US INC | $19.68 | 2023 | Quviviq |
| Myovant Sciences INC. | $18.89 | 2021 | |
| Roche Diagnostics Corporation | $18.47 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $17.85 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $15.90 | 2021 | |
| Ethicon US, LLC | $15.80 | 2023 | Dermabond, Harmonic, Stratafix |
| Merck Sharp & Dohme LLC | $14.80 | 2021 | |
| Hologic Sales and Service, LLC | $14.22 | 2021 | |
| Currax Pharmaceuticals LLC | $13.74 | 2022 | |
| Alfasigma USA, INC. | $12.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Bedont listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.